.png)
.png)
Professor
Emory University School of Medicine
Disclosure(s): GSK: Advisor/Consultant, Grant/Research Support; Janssen: Advisor/Consultant, Grant/Research Support; Kentucky Bioprocessing, Inc: Data Safety Monitoring Board; MedImmune: Grant/Research Support; Medscape: Advisor/Consultant; Merck: Grant/Research Support; Micron: Grant/Research Support; NIH: Funding from NIH to conduct clinical trials of Moderna and Janssen COVID-19 vaccines; PaxVax: Grant/Research Support; Pfizer: Advisor/Consultant, Grant/Research Support; Regeneron: Grant/Research Support; Sanofi Pasteur: Advisor/Consultant, Data Adjudication and Data Safety Monitoring Boards, Grant/Research Support; WCG and ACI Clinical: Data Adjudication Board
Evan J. Anderson is Professor of Pediatrics and Medicine at Emory University School of Medicine. He graduated summa cum laude from Wheaton College, IL after which he pursued his medical degree at the University of Chicago Pritzker School of Medicine. He remained at the University of Chicago for residency in both internal medicine and pediatrics before completing an adult and a pediatric infectious diseases fellowship at Northwestern Memorial and Children’s Memorial Hospitals in Chicago. As such, he is board certified in internal medicine, adult infectious diseases, pediatrics and pediatric infectious diseases and splits his clinical care between adults and children. He moved from Northwestern to Emory University in 2012 where is an attending physician at Children’s Healthcare of Atlanta in pediatric infectious diseases and Emory University Hospital in adult infectious diseases. He serves as the lead investigator in Georgia for influenza, RSV, and COVID-19 surveillance for the CDC-funded Emerging Infections Program. He is currently one of the multiple PIs of the Emory University Vaccine and Treatment Evaluation Unit (VTEU) and has been intricately involved with COVID-19 vaccine clinical trials in adults and children. He particularly enjoys mentoring trainees at all levels and has over 200 total publications with particular interest in rotavirus, RSV, influenza, COVID-19, early phase vaccine clinical trials, and the power of community protection.